NCT06293898 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06285097 A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06265285 Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program Status RECRUITING Phase PHASE2
NCT06262516 Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma Status RECRUITING Phase NA
NCT06221774 Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06218433 Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study) Status RECRUITING Phase NA
NCT06193941 Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits Status COMPLETED Phase N/A
NCT06178601 A Study of RC48-ADC Combined With Cadonilimab(AK104)in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma Status RECRUITING Phase PHASE2
NCT06138561 Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments Status RECRUITING Phase N/A
NCT06120374 Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC Status RECRUITING Phase N/A
NCT06111235 A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06101290 Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) Status RECRUITING Phase NA
NCT06047379 Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis Status RECRUITING Phase PHASE1/PHASE2
NCT06040762 A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial Status RECRUITING Phase NA
NCT06034860 Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types Status TERMINATED Phase PHASE1